PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 186 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $208,952 | -22.9% | 7,151 | +58.5% | 0.01% | +57.1% |
Q3 2020 | $271,000 | +23.2% | 4,512 | +7.7% | 0.01% | +75.0% |
Q2 2020 | $220,000 | +0.5% | 4,188 | -27.2% | 0.00% | -20.0% |
Q1 2019 | $219,000 | -51.5% | 5,752 | -41.9% | 0.01% | -16.7% |
Q4 2017 | $452,000 | +74.5% | 9,903 | +23.4% | 0.01% | +100.0% |
Q4 2016 | $259,000 | -44.9% | 8,023 | -42.5% | 0.00% | -40.0% |
Q2 2016 | $470,000 | – | 13,944 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Doma Perpetual Capital Management LLC | 1,000,761 | $28,631,772 | 13.28% |
GAGNON SECURITIES LLC | 596,591 | $17,068,469 | 3.84% |
Sio Capital Management, LLC | 455,500 | $13,031,855 | 3.53% |
Gagnon Advisors, LLC | 133,390 | $3,816,288 | 2.91% |
AlphaCentric Advisors LLC | 117,500 | $3,361,675 | 2.48% |
ARDSLEY ADVISORY PARTNERS LP | 580,000 | $16,593,800 | 2.44% |
RICE HALL JAMES & ASSOCIATES, LLC | 998,625 | $28,570,661 | 1.71% |
Lisanti Capital Growth, LLC | 138,830 | $3,971,926 | 0.96% |
Bridge City Capital, LLC | 84,856 | $2,427,730 | 0.82% |
Rock Springs Capital Management LP | 785,000 | $22,458,850 | 0.68% |